147 related articles for article (PubMed ID: 38468436)
21. Lower Expression of GBP2 Associated With Less Immune Cell Infiltration and Poor Prognosis in Skin Cutaneous Melanoma (SKCM).
Zhang S; Chen K; Zhao Z; Zhang X; Xu L; Liu T; Yu S
J Immunother; 2022 Jul-Aug 01; 45(6):274-283. PubMed ID: 35543550
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma.
Jiang Y; Zhang C; Zhang J; Han D; Shi X
Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233
[TBL] [Abstract][Full Text] [Related]
23. Prognostic and immune-related value of complement C1Q (C1QA, C1QB, and C1QC) in skin cutaneous melanoma.
Yang H; Che D; Gu Y; Cao D
Front Genet; 2022; 13():940306. PubMed ID: 36110204
[No Abstract] [Full Text] [Related]
24. Dysregulation of SNHG16(lncRNA)-Hsa-Let-7b-5p(miRNA)-TUBB4A (mRNA) Pathway Fuels Progression of Skin Cutaneous Melanoma.
Chen G; Yan J
Curr Protein Pept Sci; 2022; 23(11):791-809. PubMed ID: 36173063
[TBL] [Abstract][Full Text] [Related]
25. Gene Expression Changes in Cytokine and Chemokine Receptors in Association with Melanoma Liver Metastasis.
Koroknai V; Szász I; Balázs M
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240247
[TBL] [Abstract][Full Text] [Related]
26. LSM2 is associated with a poor prognosis and promotes cell proliferation, migration, and invasion in skin cutaneous melanoma.
Sun X; Zhang J; Hu J; Han Q; Ge Z
BMC Med Genomics; 2023 Jun; 16(1):129. PubMed ID: 37312186
[TBL] [Abstract][Full Text] [Related]
27. Functional Involvement of ADRA1D in Cutaneous Melanoma Progression and Angiogenesis.
Wang J; Ning D; Xie D; Chen X; Cao X; Wan C
Cell Mol Biol (Noisy-le-grand); 2023 May; 69(5):44-50. PubMed ID: 37571902
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of p38 and ERK1/2 pathways by Sparstolonin B suppresses inflammation-induced melanoma metastasis.
Tang YM; Cao QY; Guo XY; Dong SH; Duan JA; Wu QN; Liang QL
Biomed Pharmacother; 2018 Feb; 98():382-389. PubMed ID: 29276966
[TBL] [Abstract][Full Text] [Related]
29. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
Lo C; Lai TY; Yang JS; Yang JH; Ma YS; Weng SW; Lin HY; Chen HY; Lin JG; Chung JG
Melanoma Res; 2011 Aug; 21(4):267-73. PubMed ID: 21734530
[TBL] [Abstract][Full Text] [Related]
30. Adult mice with targeted mutation of the interleukin-11 receptor (IL11Ra) display normal hematopoiesis.
Nandurkar HH; Robb L; Tarlinton D; Barnett L; Köntgen F; Begley CG
Blood; 1997 Sep; 90(6):2148-59. PubMed ID: 9310465
[TBL] [Abstract][Full Text] [Related]
31. Genetic Target Modulation Employing CRISPR/Cas9 Identifies Glyoxalase 1 as a Novel Molecular Determinant of Invasion and Metastasis in A375 Human Malignant Melanoma Cells In Vitro and In Vivo.
Jandova J; Perer J; Hua A; Snell JA; Wondrak GT
Cancers (Basel); 2020 May; 12(6):. PubMed ID: 32466621
[TBL] [Abstract][Full Text] [Related]
32. Activation of stat3 in human melanoma promotes brain metastasis.
Xie TX; Huang FJ; Aldape KD; Kang SH; Liu M; Gershenwald JE; Xie K; Sawaya R; Huang S
Cancer Res; 2006 Mar; 66(6):3188-96. PubMed ID: 16540670
[TBL] [Abstract][Full Text] [Related]
33. Role of β-catenin signaling in the anti-invasive effect of the omega-3 fatty acid DHA in human melanoma cells.
Serini S; Zinzi A; Ottes Vasconcelos R; Fasano E; Riillo MG; Celleno L; Trombino S; Cassano R; Calviello G
J Dermatol Sci; 2016 Nov; 84(2):149-159. PubMed ID: 27600927
[TBL] [Abstract][Full Text] [Related]
34. B7H6 silencing increases chemosensitivity to dacarbazine and suppresses cell survival and migration in cutaneous melanoma.
Mohammadi A; Najafi S; Amini M; Baradaran B; Firouzamandi M
Melanoma Res; 2023 Jun; 33(3):173-183. PubMed ID: 37053079
[TBL] [Abstract][Full Text] [Related]
35. Enhancing antitumor immunity and achieving tumor eradication with IL11RA mRNA immunotherapy.
Ur Rehman A; Wang Z; Qin Q; Zhang X; Akhtar A; Liu H; Mao B; Khan N; Tang L; Li X
Int Immunopharmacol; 2024 Jun; 134():112205. PubMed ID: 38718659
[TBL] [Abstract][Full Text] [Related]
36. The role of NLRP3 in the prognosis and immune infiltrates of skin cutaneous melanoma (SKCM).
Wu S; Zang Q; Dai B
Transl Cancer Res; 2021 Apr; 10(4):1692-1702. PubMed ID: 35116494
[TBL] [Abstract][Full Text] [Related]
37. Combination therapy of PKCζ and COX-2 inhibitors synergistically suppress melanoma metastasis.
Zhou P; Qin J; Li Y; Li G; Wang Y; Zhang N; Chen P; Li C
J Exp Clin Cancer Res; 2017 Sep; 36(1):115. PubMed ID: 28865485
[TBL] [Abstract][Full Text] [Related]
38. ZNF23 Suppresses Cutaneous Melanoma Cell Malignancy via Mitochondria-Dependent Pathway.
Zhang X; Ding C; Tian H; Dong X; Meng X; Zhu W; Liu B; Wang L; Huang M; Li C
Cell Physiol Biochem; 2017; 43(1):147-157. PubMed ID: 28848158
[TBL] [Abstract][Full Text] [Related]
39. Mining database for the clinical significance and prognostic value of CBX family in skin cutaneous melanoma.
Li D; Liu Y; Hao S; Chen B; Li A
J Clin Lab Anal; 2020 Dec; 34(12):e23537. PubMed ID: 32860274
[TBL] [Abstract][Full Text] [Related]
40. Diallyl trisulfide inhibits cell migration and invasion of human melanoma a375 cells via inhibiting integrin/facal adhesion kinase pathway.
Wang HC; Chu YL; Hsieh SC; Sheen LY
Environ Toxicol; 2017 Nov; 32(11):2352-2359. PubMed ID: 28741790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
